Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis

Molecular Cell

Volumn 8, Issue 6, 2001, Pages 1255-1266

  Irminger Finger, Irmgard ^a   Leung, Wai Choi ^d   Li, Jian ^a   Dubois Dauphin, Michel ^b   Harb, Jean ^e   Feki, Anis ^a,b   Jefford, Charles Edward ^a   Soriano, Jesus V ^c   Jaconi, Marisa ^a   Montesano, Roberto ^c   Krause, Karl Heinz ^a  

^a Biology of Aging Laboratory   (Switzerland)

^b Department of Psychiatry ^*  (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; MESSENGER RNA; PROTEIN DERIVATIVE; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE MODEL; GENE MUTATION; GENE OVEREXPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MEDIATOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 18244399879     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00406-3     Document Type: Article

References (33)

1. BRCA1 is a selective co-activator of 14-3-3 sigma gene expression in mouse embryonic stem cells
2. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein
3. Molecular modeling of the amino-terminal zinc ring domain of BRCA1
4. The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer
5. P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells
6. Ultrastructure of the normal menstrual cycle
7. RING for destruction?
8. Identification of an apoptotic cleavage product of BARD1 as an autoantigen: A potential factor in the antitumoral response mediated by apoptotic bodies
9. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: Distinctive spectrum and structural distribution
10. Developmental studies of Brca1 and Brca2 knock-out mice
11. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1
12. The RING heterodimer BRCA1-BARD1 is an ubiquitin ligase inactivated by a breast cancer-derived mutation
13. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
14. In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells
15. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50
16. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression
17. Regulation of p53 in response to DNA damage
18. Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes ofBrca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos
19. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia
20. Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA and BARD1
21. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
22. Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis
23. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation
24. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
25. In search of the tumour-suppressor functions of BRCA1 and BRCA2
26. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
27. The cellular response to p53: The decision between life and death
28. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells
29. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers
30. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines
31. Identification of a RING protein that can interact in vivo with the BRCA1 gene product
32. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
33. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas